Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes
Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). Diagnostic confirmation and programmed follow up of these patien...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Lenguaje: | Spanish / Castilian |
| Publicado: |
Sociedad Médica de Santiago
2014
|
| Materias: | |
| Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000500002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:scielo:S0034-98872014000500002 |
|---|---|
| record_format |
dspace |
| spelling |
oai:scielo:S0034-988720140005000022014-10-10Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientesNogales-Gaete,JorgeAracena,RodrigoCepeda-Zumaeta,SergioEloiza,ClaudioAgurto,PaulaDíaz,VanniaLabbé,SilviaMartínez,SéforaFlores,JazmínAraya,Casandra Disease progression Immunomodulation Multiple Sclerosisi Relapsin-Remitting Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). Diagnostic confirmation and programmed follow up of these patients is carried out at a public national reference center. Aim: To describe the epidemiological and clinical features of 314 patients evaluated in this center between 2008 and 2012. Patients and Methods: Review of clinical records, to obtain information about demographic background, medical history, expanded disability status scale of Kurtzke (EDSS), multiple sclerosis functional composite (MSfic), intensity fatigue scale of Krupp, Raos Brief Repeatable Battery of Neuropsychological Tests (BNR-R) and anxious-depressive manifestations using Hamilton and Beck questionnaires. Results: The ages of patients ranged from 12 to 63 years and 67% were women. The initial symptoms were sensory disturbances in 20%, motor alterations in 18% and optical neuritis in 16%. In 9% of patients, the disease began with several manifestations. The EDSS was 4 or less in 73% of patients and cognitive impairment was observed in 34%. Treatment failure during the first and second years, occurred in 23 and 26% of patients, respectively. Male gender, age under 40 and brainstem malfunction at the onset of disease, were predictive of treatment failure during the second year. Conclusions: The features of these patients are very similar to those reported abroad.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.142 n.5 20142014-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000500002es10.4067/S0034-98872014000500002 |
| institution |
Scielo Chile |
| collection |
Scielo Chile |
| language |
Spanish / Castilian |
| topic |
Disease progression Immunomodulation Multiple Sclerosisi Relapsin-Remitting |
| spellingShingle |
Disease progression Immunomodulation Multiple Sclerosisi Relapsin-Remitting Nogales-Gaete,Jorge Aracena,Rodrigo Cepeda-Zumaeta,Sergio Eloiza,Claudio Agurto,Paula Díaz,Vannia Labbé,Silvia Martínez,Séfora Flores,Jazmín Araya,Casandra Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes |
| description |
Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). Diagnostic confirmation and programmed follow up of these patients is carried out at a public national reference center. Aim: To describe the epidemiological and clinical features of 314 patients evaluated in this center between 2008 and 2012. Patients and Methods: Review of clinical records, to obtain information about demographic background, medical history, expanded disability status scale of Kurtzke (EDSS), multiple sclerosis functional composite (MSfic), intensity fatigue scale of Krupp, Raos Brief Repeatable Battery of Neuropsychological Tests (BNR-R) and anxious-depressive manifestations using Hamilton and Beck questionnaires. Results: The ages of patients ranged from 12 to 63 years and 67% were women. The initial symptoms were sensory disturbances in 20%, motor alterations in 18% and optical neuritis in 16%. In 9% of patients, the disease began with several manifestations. The EDSS was 4 or less in 73% of patients and cognitive impairment was observed in 34%. Treatment failure during the first and second years, occurred in 23 and 26% of patients, respectively. Male gender, age under 40 and brainstem malfunction at the onset of disease, were predictive of treatment failure during the second year. Conclusions: The features of these patients are very similar to those reported abroad. |
| author |
Nogales-Gaete,Jorge Aracena,Rodrigo Cepeda-Zumaeta,Sergio Eloiza,Claudio Agurto,Paula Díaz,Vannia Labbé,Silvia Martínez,Séfora Flores,Jazmín Araya,Casandra |
| author_facet |
Nogales-Gaete,Jorge Aracena,Rodrigo Cepeda-Zumaeta,Sergio Eloiza,Claudio Agurto,Paula Díaz,Vannia Labbé,Silvia Martínez,Séfora Flores,Jazmín Araya,Casandra |
| author_sort |
Nogales-Gaete,Jorge |
| title |
Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes |
| title_short |
Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes |
| title_full |
Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes |
| title_fullStr |
Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes |
| title_full_unstemmed |
Esclerosis múltiple recurrente remitente en el sector público de salud de Chile: Descripción clínica de 314 pacientes |
| title_sort |
esclerosis múltiple recurrente remitente en el sector público de salud de chile: descripción clínica de 314 pacientes |
| publisher |
Sociedad Médica de Santiago |
| publishDate |
2014 |
| url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000500002 |
| work_keys_str_mv |
AT nogalesgaetejorge esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT aracenarodrigo esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT cepedazumaetasergio esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT eloizaclaudio esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT agurtopaula esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT diazvannia esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT labbesilvia esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT martinezsefora esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT floresjazmin esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes AT arayacasandra esclerosismultiplerecurrenteremitenteenelsectorpublicodesaluddechiledescripcionclinicade314pacientes |
| _version_ |
1718436753342201856 |